Vaccination coverage and immunity against hepatitis B among HIV-infected patients in South Brazil

World Health Organization, 2013 World Health Organization, 2013 Ockenga, 1997, Hepatitis B and C in HIV-infected patients, J Hepatol, 27, 18, 10.1016/S0168-8278(97)80274-7 Alter, 2006, Epidemiology of viral hepatitis and HIV co-infection, J Hepatol, 44, S6, 10.1016/j.jhep.2005.11.004 Lee, 2008, Seroprevalence of viral hepatitis and sexually transmitted disease among adults with recently diagnosed HIV infection in Southern Taiwan, 2000–2005: upsurge in hepatitis C virus infections among injection drug users, J Formos Med Assoc, 107, 404, 10.1016/S0929-6646(08)60106-0 Hu, 1991, Transmission of HIV, hepatitis B virus, and other bloodborne pathogens in health care settings: a review of risk factors and guidelines for prevention, Bull World Health Organ, 69, 623 Colin, 1999, Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men, Hepatology, 29, 1306, 10.1002/hep.510290447 Thio, 2002, HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter AIDS Cohort Study (MACS), Lancet, 360, 1921, 10.1016/S0140-6736(02)11913-1 Hoffmann, 2007, Clinical implications of HIV and hepatitis B co-infection in Asia and Africa, Lancet Infect Dis, 7, 402, 10.1016/S1473-3099(07)70135-4 Centers for Disease Control and Prevention, 2012, Recommended adult immunization schedule – United States, 2012, MMWR, 61, 1 Rey, 2000, Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load, Vaccine, 18, 1161, 10.1016/S0264-410X(99)00389-8 Tedaldi, 2004, Hepatitis A and B vaccination practices for ambulatory patients infected with HIV, Clin Infect Dis, 38, 1478, 10.1086/420740 Fonseca, 2005, Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose, Vaccine, 23, 2902, 10.1016/j.vaccine.2004.11.057 Launay, 2011, Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial, JAMA, 305, 1432, 10.1001/jama.2011.351 de Vries-Sluijs, 2011, A randomized controlled study of accelerated versus standard hepatitis B vaccination in HIV-positive patients, J Infect Dis, 203, 984, 10.1093/infdis/jiq137 Mena, 2012, Assessing the immunological response to hepatitis B vaccination in HIV-infected patients in clinical practice, Vaccine, 30, 3703, 10.1016/j.vaccine.2012.03.018 Teixeira, 2003, 69 Brazilian Health Ministry, 2013 Brazilian Ministry of Health, 2003 Brazilian Ministry of Health, 2013 Brazilian Ministry of Health, National Health Foundation, 2001 Brazilian Ministry of Health, 2002 Tonial, 2011, Hepatitis B marker seroprevalence and vaccination coverage in adolescents in the city of Itajaí, State of Santa Catarina, southern Brazil, in 2008, Rev Soc Bras Med Trop, 44, 416, 10.1590/S0037-86822011000400003 Scaraveli, 2011, Seroprevalence of hepatitis B and hepatitis C markers in adolescents in Southern Brazil, Cad Saude Publica, 27, 753, 10.1590/S0102-311X2011000400014 Passos, 2011, Hepatitis B immunity and vaccination coverage among young adult males in the Air Force in South Brazil, Vaccine, 29, 9284, 10.1016/j.vaccine.2011.06.050 Price, 2012, Hepatitis B virus infection in HIV-positive individuals in the UK collaborative HIV cohort (UK CHIC) study, PLoS ONE, 7, e49314, 10.1371/journal.pone.0049314 de Vries-Sluijs, 2008, A prospective open study of the efficacy of high-dose recombinant hepatitis B rechallenge vaccination in HIV-infected patients, J Infect Dis, 197, 292, 10.1086/524690 Landrum, 2009, Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: another benefit of HAART in those with preserved CD4 count, Vaccine, 27, 4731, 10.1016/j.vaccine.2009.04.016 Voigt, 2010, Seroprevalence of hepatitis B and hepatitis C markers among children and adolescents in the south Brazilian region – metropolitan area of Florianopolis, Santa Catarina, Braz J Infect Dis, 14, 60 Livramento, 2011, Anti-HBs levels among children and adolescents with complete immunization schedule against hepatitis B virus. A cross-sectional study in Blumenau, State of Santa Catarina, Brazil, 2007–2008, Rev Soc Bras Med Trop, 44, 412, 10.1590/S0037-86822011005000046 Poovorawan, 2010, Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand, Vaccine, 28, 730, 10.1016/j.vaccine.2009.10.074 Potsch, 2012, Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults, Vaccine, 30, 5973, 10.1016/j.vaccine.2012.07.028 Valdez, 2000, Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team. AIDS Clinical Trials Group, AIDS, 14, 11, 10.1097/00002030-200001070-00002 Paitoonpong, 2008, Immunological response to hepatitis B vaccination in patients with AIDS and virological response to highly active antiretroviral therapy, Scand J Infect Dis, 40, 54, 10.1080/00365540701522975 Overton, 2005, Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIV-infected persons, Clin Infect Dis, 41, 1045, 10.1086/433180 Veiga, 2006, Humoral response to hepatitis B vaccination and its relationship with T CD45 RA+ (naive) and CD45 RO+ (memory) subsets in HIV-1-infected subjects, Vaccine, 24, 7124, 10.1016/j.vaccine.2006.06.079 Neri, 2002, Social inequality and health in Brazil, Cad Saude Publica, 18, 77, 10.1590/S0102-311X2002000700009